Home » Topics » Conferences

Conferences
RSS

Cannabinoid antagonist SR-141716 may be effective in treatment of alcoholism and appetite disorders

Aug. 19, 1998

Kissei studies beta-adrenergic drug for use in patients with urolithiasis

Aug. 18, 1998

SB-237376, a new antiarrhythmic agent with a dual mechanism of action and enhanced safety

Aug. 18, 1998

Nonamine compounds inhibit monoamine transporters, contrary to prevailing beliefs

Aug. 18, 1998

Positive inotropic agent YS-49 shows potential in the treatment of septic shock

Aug. 17, 1998

Novel venotropic agent discovered by Innothera

Aug. 17, 1998

PST-2107, an inotropic agent with potential to outshine digoxin

Aug. 17, 1998

No negative cardiovascular effects seen in dogs administered NC-100100

Aug. 17, 1998

Gidazepam, a new benzodiazepine anxiolytic with potential in asthenic disorders

Aug. 17, 1998

Unique agent for cognition disorders: GTS-21, a nicotinic acetylcholine agonist

Aug. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026